Posted in | News | Nanomaterials | Nanoanalysis

Rice University Chemist to Testify About Nanotechnology

Rice University chemist James Tour will testify before the Energy and Commerce Subcommittee on Commerce, Manufacturing and Trade at 10:15 a.m. EDT July 29.

Nanotechnology" />
James Tour

At the hearing, titled “Nanotechnology: Understanding How Small Solutions Drive Big Innovation,” Tour will discuss and provide written testimony on the future of nanotechnology and its impact on U.S. manufacturing and jobs. Tour is one of the most cited chemists in the country, and his Tour Group is a leader in patenting and bringing to market nanotechnology-based methods and materials.

Who: James Tour, Rice’s T.T. and W.F. Chao Chair in Chemistry and professor of materials science and nanoengineering and of computer science.

What: Exploring breakthrough nanotechnology opportunities.

When: 10:15 a.m. EDT Tuesday, July 29.

Where: Room 2322, Rayburn House Office Building, Washington, D.C.

The hearing will explore the current state of nanotechnology and the direction it is headed so that members can gain a better understanding of the policy changes that may be necessary to keep up with advancements. Ultimately, the subcommittee hopes to better understand what issues will confront regulators and how to assess the challenges and opportunities of nanotechnology.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.